## Summary

This paper is a point-by-point rebuttal of a recent TPAMI response (Palazzo et al., 2024) that raised concerns about a comment (Bharadwaj et al., 2023) and the underlying EEG data collection (Ahmed et al., 2021). The authors argue that numerous claims in Palazzo et al. (2024) are unfounded, inaccurate, or misleading, supporting their position with textual evidence from the original papers and new analyses (e.g., frequency-domain supertrial averaging).

## Strengths

- **Clear and systematic refutation:** Each claim from Palazzo et al. (2024) is quoted and directly addressed with specific evidence, making the arguments easy to follow and evaluate.
- **New empirical analyses:** The paper contributes new experiments (frequency-domain supertrial averaging, Figure 1 and Table 1) that demonstrate the robustness of the original supertrial analysis to different averaging methods, adding constructive evidence beyond textual rebuttal.
- **Well-supported citations:** The authors consistently ground their arguments in the original source materials (Ahmed et al., 2021; Bharadwaj et al., 2023; Li et al., 2021; Spampinato et al., 2017), making the claims verifiable.

## Weaknesses

### Fatal
None.

### Major
- **Limited scope and significance for ICLR:** The paper is a rebuttal of a rebuttal, correcting specific statements in a single response paper. While the arguments may be correct, the overall contribution is narrow and primarily rhetorical/corrective. It does not present a novel machine learning method, new representation learning insight, or a broad empirical finding that would be of central interest to the ICLR community. The paper would be more appropriate for a forum, commentary section, or a specialized journal.
- **Lack of novelty in methodology or theory:** The core claim—that certain EEG classification results are confounded by temporal correlations—has been extensively documented in prior work (Li et al., 2021; Bharadwaj et al., 2023; Ahmed et al., 2021). The new experiments (frequency-domain averaging) are a helpful demonstration, but they primarily reinforce existing claims rather than opening new directions.

### Minor
- **Assumes deep familiarity with the debate:** The paper jumps directly into refuting specific claims without providing sufficient context for readers not already following this controversy. This limits accessibility and impact.
- **Ethics statement overreach:** The ethics section makes sweeping claims about harm to disabled communities and lists ~100 flawed papers, but the connection between these papers and the specific confound is asserted rather than systematically argued within the review.

### Trivial
- The adversarial title and tone are stylistic choices that do not affect technical soundness.

## Nice-to-Haves

- A brief introduction summarizing the history of the confound debate (from Spampinato et al., 2017 through Li et al., 2021, Bharadwaj et al., 2023, and the TPAMI response) would make the paper self-contained for a broader audience.
- A table summarizing which specific claims were refuted and how would improve clarity.

## Novel Insights

None beyond the paper's own contributions (the frequency-domain supertrial averaging demonstration and the detailed refutation of specific claims). The overall insight—that the confound critique remains valid—has been established in prior work.

## Suggestions

- Reframe the paper as a commentary or replication study and target a venue that specifically publishes methodological critiques (e.g., NeuroImage, a journal of neuroscience methods, or an ICLR workshop on reproducibility).
- If resubmitting to ICLR, the authors would need to connect the debate more directly to representation learning (e.g., what does this tell us about learned representations in EEG?).

## Score and Decision

**Score: 4** – The paper is well-argued and technically sound, but its narrow scope and absence of significant novelty in representation learning or methodology make it a borderline reject for ICLR. The contribution is primarily corrective and more suited to a specialized or commentary venue.

MY FINAL SCORE: 4</score>  
MY FINAL DECISION: Reject</decision>